Abstract:Objective:To analyze the clinical characteristics of patients with COPD who are more likely to develop lung cancer, and the cancer risk factors conferred by COPD. Therefore, we can get a better understanding of the mechanisms linking the two diseases and the implementation of lung cancer screening in high risks population of patients with COPD which potentially result in more timely early diagnosis and treatment.Methods:A retrospective study was performed in 195 patients with COPD and lung cancer who were admitted in the Respiratory and Thoracic surgery of the Second Affiliated Hospital of Xi′an Jiaotong University between March 2017 and December 2019. Additionally, in the same time another cohort consisting of 189 hospitalized COPD patients without lung cancer were recruited as negative control set.Results:the percentage of older population (≥60 years) and male patients in COPD patients with lung cancer (COPD/LC) was significantly higher than that in COPD-only group, and the categorical analysis of smoking populations and subgroup of HSI ≥400 revealed considerably larger numbers in COPD/LC group than those in COPD-only group (all P<0.05); The prevalence of a range of symptoms was notably higher in COPD/LC group than those in COPD-only group, including hemoptysis, chest pain, pleural effusion, fatigue, and weight loss (all P>0.05); The pH value and FEV1 value of COPD/LC group was apparently higher than that of COPD-only group, and compared to COPD-only set, COPD/LC group exhibited larger population of patients with GOLD grade Ⅱ (all P<0.05); The values of a set of laboratory tests were clearly elevated in COPD/LC group than those in COPD-only group, including WBC, PLT, NEUT, EO, EO%, PT, INR, FIB, PFDP and CRP (all P<0.05); There were mainly effective ways we performed to diagnose COPD patients with lung cancer is bronchoscopy. the main lesion distribution of 195 COPD/LC patients was in the right lung. the main tumor sub-location was central-type lung cancer. The mainly histopathological type in male was SCC, and in female was AC. the mainly TNM staging system of lung cancer are stage Ⅲ/Ⅳ. In addition, 131 out of 195 COPD/LC patients were found distant metastasis at the time of initial diagnosis with lung cancer; The proportion of patients receiving ICS treatment in COPD-only group was significantly higher than that in COPD/LC group (P<0.01); the potential lung cancer risk factors in COPD patients included smoking, higher eosinophil count, as well as elevated levels of fibrinogen, and the protective factors was inhalation of ICS.Conclusions:COPD patients should adhere to regular inhaled ICS treatment. The COPD patients with a history of hemoptysis, chest pain, pleural effusion, fatigue and weight loss during the illness, or with symptoms such as elevated platelet, eosinophil count, blood coagulation index, and CRP, may be at increased risks of becoming lung cancer and do need to be altered.

A retrospective study of clinical features of patients with emphysema complicated with lung cancer

Comparison between young and old patients with lung cancer

Incidentally Diagnosed with Pulmonary Embolism in Lung Cancer Patients: Comparison of Clinical Characteristics and Mortality with Symptomatic Pulmonary Embolism

CEA, SCC and NSE levels in exhaled breath condensate--possible markers for early detection of lung cancer.

Effect of Emphysema on Lung Cancer Risk in Smokers: A Computed Tomography–Based Assessment

Computed Tomography Characterization of Emphysema in Combined Pulmonary Fibrosis and Emphysema (CPFE) and Its Correlation with Lung Cancer with Comparison to Chronic Obstructive Pulmanory Disease (COPD)

Meta-analysis: clinical features and treatments of lung cancer in combined pulmonary fibrosis and emphysema

Clinical significance of CEA and CK20 expression in exfoliated cells by fiberoptic bronchoscopy brushing

Clinical Features Of Pulmonary Embolism In Patients With Lung Cancer: A Meta-Analysis

Lung Cancer in Patients with Combined Pulmonary Fibrosis and Emphysema Revisited with the 2015 World Health Organization Classification of Lung Tumors.

A Real-World Observational Study To Explore Clinical Characteristics Of Chinese Patients With T1 Non-Small Cell Lung Cancer Complicated With Lymph Metastases.

Changes Of Tumor Markers And C Reactive Protein In Different Status Of Lung Cancer

Clinical characteristics and outcomes of lung cancer patients with combined pulmonary fibrosis and emphysema: a systematic review and meta-analysis of 13 studies.

Analysis of clinical features and risk factors of COPD patients with lung cancer

Influence of the type of emphysema in the relationship between COPD and lung cancer

Clinical characteristics and radiological appearance in patients with combined pulmonary fibrosis and emphy-sema syndrome

Clinical characteristics of the emphysema phenotype of chronic obstructive pulmonary disease at acute exacerbations

Incidence of metabolic syndrome and non-alcoholic fatty liver diseases in patients with different histological types of lung cancer

Clinical analysis of 141 cases of elderly patients with lung cancer

P1.03-011 Clinical Characters of 19 Bronchial Asthmatic Patients with Lung Cancer

Clinical retrospective observation of lung cancer between young and elderly patients